{"id":"W2137323340","doi":"10.1186/1477-7525-11-82","title":"Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study","year":2013,"lang":"en","type":"article","venue":"Health and Quality of Life Outcomes","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Celgene","keywords":"Apremilast; Medicine; Placebo; Minimal clinically important difference; Dermatology Life Quality Index; Psoriasis; Quality of life (healthcare); Visual analogue scale; Randomized controlled trial; Internal medicine; Physical therapy; Dermatology; Alternative medicine; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009096592,0.001150316,0.00300562,0.0004515479,0.0004465935,0.001063882,0.0009471434,0.001685608,0.004480599],"category_scores_gemma":[0.005401823,0.0005201026,0.003433162,0.0007552951,0.001005441,0.0006725608,0.000342138,0.001980671,0.0004018335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006141939,"about_ca_system_score_gemma":0.001244132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006113379,"about_ca_topic_score_gemma":0.001142637,"domain_scores_codex":[0.9968234,0.001977112,0.0003863835,0.0002847606,0.0003276928,0.0002005398],"domain_scores_gemma":[0.9958806,0.001614639,0.001376206,0.0002394695,0.0003074399,0.0005816855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9378429,0.008976268,0.003517222,0.00251738,0.004015001,0.00005163581,0.00009746684,0.0002284397,0.003926979,0.00005789752,0.0008521201,0.03791673],"study_design_scores_gemma":[0.8774502,0.1030285,0.0153725,0.0001957448,0.002574441,0.00006917872,0.00003161837,0.0001788836,0.0003998816,0.0000601206,0.0006200038,0.00001891642],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9642733,0.02587048,0.0009262325,0.0008293032,0.0003330874,0.004314567,0.001529878,0.0001121768,0.001810978],"genre_scores_gemma":[0.9794911,0.009719927,0.002016678,0.001427182,0.0006904338,0.00428083,0.001554667,0.00002029608,0.0007987952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009096592,"threshold_uncertainty_score":0.04810798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05339083400482784,"score_gpt":0.3399360892887135,"score_spread":0.2865452552838857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}